Preemptive therapeutic-dose anticoagulation for individuals hospitalized with COVID-19 wasn’t linked to far better outcomes in a compact observational study.
In reality, relative danger of in-hospital mortality with this approach was two.three occasions higher (P=.04) than observed with typical prophylactic dosing on multivariate evaluation, with 38.7 vs 14.four deaths per 100 individuals.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.